The global Alzheimer's Disease Therapeutics and Diagnostics market was valued at US$ 3618 million in 2023 and is anticipated to reach US$ 4024.3 million by 2030, witnessing a CAGR of 1.5% during the forecast period 2024-2030.

Alzheimer's Disease Therapeutics and Diagnostics Market

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Alzheimer's Disease Therapeutics and Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer's Disease Therapeutics and Diagnostics.

Report Scope

The Alzheimer's Disease Therapeutics and Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alzheimer's Disease Therapeutics and Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Alzheimer's Disease Therapeutics and Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Alzheimer's Disease Therapeutics and Diagnostics Market Report

Report Metric	Details
Report Name	Alzheimer's Disease Therapeutics and Diagnostics Market
Accounted market size in 2023	US$ 3618 million
Forecasted market size in 2030	US$ 4024.3 million
CAGR	1.5%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Biomarkers Cholinesterase inhibitors NMDA receptor antagonists Brain imaging Blood tests
Segment by Application	Drugs Market Diagnostics Market
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Namenda, Aricept, Exelon, Solanezumab, Gantenerumab, Verubecestat, Pfizer, Eisai, Actavis, Lundbeck, Daiichi Sankyo, Novartis, TauRx
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alzheimer's Disease Therapeutics and Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Alzheimer's Disease Therapeutics and Diagnostics Market growing?

Ans: The Alzheimer's Disease Therapeutics and Diagnostics Market witnessing a CAGR of 1.5% during the forecast period 2024-2030.

What is the Alzheimer's Disease Therapeutics and Diagnostics Market size in 2030?

Ans: The Alzheimer's Disease Therapeutics and Diagnostics Market size in 2030 will be US$ 4024.3 million.

Who are the main players in the Alzheimer's Disease Therapeutics and Diagnostics Market report?

Ans: The main players in the Alzheimer's Disease Therapeutics and Diagnostics Market are Namenda, Aricept, Exelon, Solanezumab, Gantenerumab, Verubecestat, Pfizer, Eisai, Actavis, Lundbeck, Daiichi Sankyo, Novartis, TauRx

What are the Application segmentation covered in the Alzheimer's Disease Therapeutics and Diagnostics Market report?

Ans: The Applications covered in the Alzheimer's Disease Therapeutics and Diagnostics Market report are Drugs Market, Diagnostics Market

What are the Type segmentation covered in the Alzheimer's Disease Therapeutics and Diagnostics Market report?

Ans: The Types covered in the Alzheimer's Disease Therapeutics and Diagnostics Market report are Biomarkers, Cholinesterase inhibitors, NMDA receptor antagonists, Brain imaging, Blood tests

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Biomarkers

1.2.3 Cholinesterase inhibitors

1.2.4 NMDA receptor antagonists

1.2.5 Brain imaging

1.2.6 Blood tests

1.3 Market by Application

1.3.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Drugs Market

1.3.3 Diagnostics Market

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Perspective (2019-2030)

2.2 Alzheimer's Disease Therapeutics and Diagnostics Growth Trends by Region

2.2.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Alzheimer's Disease Therapeutics and Diagnostics Historic Market Size by Region (2019-2024)

2.2.3 Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Region (2025-2030)

2.3 Alzheimer's Disease Therapeutics and Diagnostics Market Dynamics

2.3.1 Alzheimer's Disease Therapeutics and Diagnostics Industry Trends

2.3.2 Alzheimer's Disease Therapeutics and Diagnostics Market Drivers

2.3.3 Alzheimer's Disease Therapeutics and Diagnostics Market Challenges

2.3.4 Alzheimer's Disease Therapeutics and Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Alzheimer's Disease Therapeutics and Diagnostics Players by Revenue

3.1.1 Global Top Alzheimer's Disease Therapeutics and Diagnostics Players by Revenue (2019-2024)

3.1.2 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Players (2019-2024)

3.2 Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Alzheimer's Disease Therapeutics and Diagnostics Revenue

3.4 Global Alzheimer's Disease Therapeutics and Diagnostics Market Concentration Ratio

3.4.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Therapeutics and Diagnostics Revenue in 2023

3.5 Alzheimer's Disease Therapeutics and Diagnostics Key Players Head office and Area Served

3.6 Key Players Alzheimer's Disease Therapeutics and Diagnostics Product Solution and Service

3.7 Date of Enter into Alzheimer's Disease Therapeutics and Diagnostics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Alzheimer's Disease Therapeutics and Diagnostics Breakdown Data by Type

4.1 Global Alzheimer's Disease Therapeutics and Diagnostics Historic Market Size by Type (2019-2024)

4.2 Global Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Type (2025-2030)

5 Alzheimer's Disease Therapeutics and Diagnostics Breakdown Data by Application

5.1 Global Alzheimer's Disease Therapeutics and Diagnostics Historic Market Size by Application (2019-2024)

5.2 Global Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size (2019-2030)

6.2 North America Alzheimer's Disease Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2019-2024)

6.4 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size (2019-2030)

7.2 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2019-2024)

7.4 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size (2019-2030)

8.2 Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region (2019-2024)

8.4 Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size (2019-2030)

9.2 Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2019-2024)

9.4 Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size (2019-2030)

10.2 Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2019-2024)

10.4 Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Namenda

11.1.1 Namenda Company Detail

11.1.2 Namenda Business Overview

11.1.3 Namenda Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.1.4 Namenda Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.1.5 Namenda Recent Development

11.2 Aricept

11.2.1 Aricept Company Detail

11.2.2 Aricept Business Overview

11.2.3 Aricept Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.2.4 Aricept Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.2.5 Aricept Recent Development

11.3 Exelon

11.3.1 Exelon Company Detail

11.3.2 Exelon Business Overview

11.3.3 Exelon Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.3.4 Exelon Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.3.5 Exelon Recent Development

11.4 Solanezumab

11.4.1 Solanezumab Company Detail

11.4.2 Solanezumab Business Overview

11.4.3 Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.4.4 Solanezumab Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.4.5 Solanezumab Recent Development

11.5 Gantenerumab

11.5.1 Gantenerumab Company Detail

11.5.2 Gantenerumab Business Overview

11.5.3 Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.5.4 Gantenerumab Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.5.5 Gantenerumab Recent Development

11.6 Verubecestat

11.6.1 Verubecestat Company Detail

11.6.2 Verubecestat Business Overview

11.6.3 Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.6.4 Verubecestat Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.6.5 Verubecestat Recent Development

11.7 Pfizer

11.7.1 Pfizer Company Detail

11.7.2 Pfizer Business Overview

11.7.3 Pfizer Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.7.4 Pfizer Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.7.5 Pfizer Recent Development

11.8 Eisai

11.8.1 Eisai Company Detail

11.8.2 Eisai Business Overview

11.8.3 Eisai Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.8.4 Eisai Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.8.5 Eisai Recent Development

11.9 Actavis

11.9.1 Actavis Company Detail

11.9.2 Actavis Business Overview

11.9.3 Actavis Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.9.4 Actavis Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.9.5 Actavis Recent Development

11.10 Lundbeck

11.10.1 Lundbeck Company Detail

11.10.2 Lundbeck Business Overview

11.10.3 Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.10.4 Lundbeck Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.10.5 Lundbeck Recent Development

11.11 Daiichi Sankyo

11.11.1 Daiichi Sankyo Company Detail

11.11.2 Daiichi Sankyo Business Overview

11.11.3 Daiichi Sankyo Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.11.4 Daiichi Sankyo Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.11.5 Daiichi Sankyo Recent Development

11.12 Novartis

11.12.1 Novartis Company Detail

11.12.2 Novartis Business Overview

11.12.3 Novartis Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.12.4 Novartis Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.12.5 Novartis Recent Development

11.13 TauRx

11.13.1 TauRx Company Detail

11.13.2 TauRx Business Overview

11.13.3 TauRx Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.13.4 TauRx Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.13.5 TauRx Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Biomarkers

Table 3. Key Players of Cholinesterase inhibitors

Table 4. Key Players of NMDA receptor antagonists

Table 5. Key Players of Brain imaging

Table 6. Key Players of Blood tests

Table 7. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Region (2019-2024)

Table 11. Global Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Region (2025-2030)

Table 13. Alzheimer's Disease Therapeutics and Diagnostics Market Trends

Table 14. Alzheimer's Disease Therapeutics and Diagnostics Market Drivers

Table 15. Alzheimer's Disease Therapeutics and Diagnostics Market Challenges

Table 16. Alzheimer's Disease Therapeutics and Diagnostics Market Restraints

Table 17. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Players (2019-2024)

Table 19. Global Top Alzheimer's Disease Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Therapeutics and Diagnostics as of 2023)

Table 20. Ranking of Global Top Alzheimer's Disease Therapeutics and Diagnostics Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Alzheimer's Disease Therapeutics and Diagnostics Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Alzheimer's Disease Therapeutics and Diagnostics Product Solution and Service

Table 24. Date of Enter into Alzheimer's Disease Therapeutics and Diagnostics Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Type (2019-2024)

Table 28. Global Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Type (2025-2030)

Table 30. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Application (2019-2024)

Table 32. Global Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Application (2025-2030)

Table 34. North America Alzheimer's Disease Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 49. Namenda Company Detail

Table 50. Namenda Business Overview

Table 51. Namenda Alzheimer's Disease Therapeutics and Diagnostics Product

Table 52. Namenda Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 53. Namenda Recent Development

Table 54. Aricept Company Detail

Table 55. Aricept Business Overview

Table 56. Aricept Alzheimer's Disease Therapeutics and Diagnostics Product

Table 57. Aricept Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 58. Aricept Recent Development

Table 59. Exelon Company Detail

Table 60. Exelon Business Overview

Table 61. Exelon Alzheimer's Disease Therapeutics and Diagnostics Product

Table 62. Exelon Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 63. Exelon Recent Development

Table 64. Solanezumab Company Detail

Table 65. Solanezumab Business Overview

Table 66. Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Product

Table 67. Solanezumab Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 68. Solanezumab Recent Development

Table 69. Gantenerumab Company Detail

Table 70. Gantenerumab Business Overview

Table 71. Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Product

Table 72. Gantenerumab Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 73. Gantenerumab Recent Development

Table 74. Verubecestat Company Detail

Table 75. Verubecestat Business Overview

Table 76. Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Product

Table 77. Verubecestat Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 78. Verubecestat Recent Development

Table 79. Pfizer Company Detail

Table 80. Pfizer Business Overview

Table 81. Pfizer Alzheimer's Disease Therapeutics and Diagnostics Product

Table 82. Pfizer Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 83. Pfizer Recent Development

Table 84. Eisai Company Detail

Table 85. Eisai Business Overview

Table 86. Eisai Alzheimer's Disease Therapeutics and Diagnostics Product

Table 87. Eisai Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 88. Eisai Recent Development

Table 89. Actavis Company Detail

Table 90. Actavis Business Overview

Table 91. Actavis Alzheimer's Disease Therapeutics and Diagnostics Product

Table 92. Actavis Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 93. Actavis Recent Development

Table 94. Lundbeck Company Detail

Table 95. Lundbeck Business Overview

Table 96. Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Product

Table 97. Lundbeck Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 98. Lundbeck Recent Development

Table 99. Daiichi Sankyo Company Detail

Table 100. Daiichi Sankyo Business Overview

Table 101. Daiichi Sankyo Alzheimer's Disease Therapeutics and Diagnostics Product

Table 102. Daiichi Sankyo Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 103. Daiichi Sankyo Recent Development

Table 104. Novartis Company Detail

Table 105. Novartis Business Overview

Table 106. Novartis Alzheimer's Disease Therapeutics and Diagnostics Product

Table 107. Novartis Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 108. Novartis Recent Development

Table 109. TauRx Company Detail

Table 110. TauRx Business Overview

Table 111. TauRx Alzheimer's Disease Therapeutics and Diagnostics Product

Table 112. TauRx Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 113. TauRx Recent Development

Table 114. Research Programs/Design for This Report

Table 115. Key Data Information from Secondary Sources

Table 116. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Type: 2023 VS 2030

Figure 3. Biomarkers Features

Figure 4. Cholinesterase inhibitors Features

Figure 5. NMDA receptor antagonists Features

Figure 6. Brain imaging Features

Figure 7. Blood tests Features

Figure 8. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application: 2023 VS 2030

Figure 10. Drugs Market Case Studies

Figure 11. Diagnostics Market Case Studies

Figure 12. Alzheimer's Disease Therapeutics and Diagnostics Report Years Considered

Figure 13. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Region: 2023 VS 2030

Figure 16. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Players in 2023

Figure 17. Global Top Alzheimer's Disease Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Therapeutics and Diagnostics as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Alzheimer's Disease Therapeutics and Diagnostics Revenue in 2023

Figure 19. North America Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Alzheimer's Disease Therapeutics and Diagnostics Market Share by Country (2019-2030)

Figure 21. United States Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Share by Country (2019-2030)

Figure 25. Germany Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Share by Region (2019-2030)

Figure 33. China Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Share by Country (2019-2030)

Figure 41. Mexico Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Share by Country (2019-2030)

Figure 45. Turkey Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Namenda Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 48. Aricept Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 49. Exelon Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 50. Solanezumab Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 51. Gantenerumab Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 52. Verubecestat Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 53. Pfizer Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 54. Eisai Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 55. Actavis Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 56. Lundbeck Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 57. Daiichi Sankyo Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 58. Novartis Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 59. TauRx Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions